RT @CIR_AACR: ➡️ The effects of intralesional IL2 therapy in #melanoma are identified in this study by @MaryamPourm, Mellinghoff, Hollmann…
RT @CIR_AACR: ➡️ The effects of intralesional IL2 therapy in #melanoma are identified in this study by @MaryamPourm, Mellinghoff, Hollmann…
RT @CIR_AACR: ➡️ The effects of intralesional IL2 therapy in #melanoma are identified in this study by @MaryamPourm, Mellinghoff, Hollmann…
➡️ The effects of intralesional IL2 therapy in #melanoma are identified in this study by @MaryamPourm, Mellinghoff, Hollmann et al. https://t.co/avJgfHWHs4 @TBrennster @evanlipson @MikeWhiteMD @jmkirkwood @slgoff_SB @JenWargoMD #AACR22 https://t.co/pXas4Q3
RT @CIR_AACR: #CIRcover for the March issue! "Tumor MHC Class I Expression Associates with Intralesional IL2 Response in #Melanoma" by @Mar…
#CIRcover for the March issue! "Tumor MHC Class I Expression Associates with Intralesional IL2 Response in #Melanoma" by @MaryamPourm, Mellinghoff, Hollmann et al. https://t.co/gllHIInwSp @TBrennster @evanlipson @MikeWhiteMD @jmkirkwood @slgoff_SB @JenWarg
RT @CIR_AACR: #CIRcover for the March issue! "Tumor MHC Class I Expression Associates with Intralesional IL2 Response in #Melanoma" by @Mar…
RT @MaryamPourm: Featured on the cover!
Featured on the cover!
#CIRcover for the March issue! "Tumor MHC Class I Expression Associates with Intralesional IL2 Response in #Melanoma" by @MaryamPourm, Mellinghoff, Hollmann et al. https://t.co/FlEDeuEtH6 @TBrennster @evanlipson @MikeWhiteMD @jmkirkwood @slgoff_SB @JenWarg
#ICYMI: Tumor MHC Class I Expression Associates with Intralesional IL2 Response in #Melanoma by Riedel, Shields et al. https://t.co/59QvP6X74B @_WolfLab @FrezzaLab https://t.co/oDa5JgZNZu
RT @CIR_AACR: #OnlineFirst: Tumor MHC Class I Expression Associates with Intralesional IL2 Response in #Melanoma by Riedel, Shields et al.…
RT @CIR_AACR: #OnlineFirst: Tumor MHC Class I Expression Associates with Intralesional IL2 Response in #Melanoma by Riedel, Shields et al.…
RT @CIR_AACR: #OnlineFirst: Tumor MHC Class I Expression Associates with Intralesional IL2 Response in #Melanoma by Riedel, Shields et al.…
#OnlineFirst: Tumor MHC Class I Expression Associates with Intralesional IL2 Response in #Melanoma by Riedel, Shields et al. https://t.co/bWb2GgrGON @_WolfLab @FrezzaLab https://t.co/aJMq4C4HcV
RT @MaryamPourm: Excited to share my first author paper in @CIR_AACR where we demonstrate loss of tumor MHC class I associates with resista…
RT @MaryamPourm: Excited to share my first author paper in @CIR_AACR where we demonstrate loss of tumor MHC class I associates with resista…
RT @MaryamPourm: Excited to share my first author paper in @CIR_AACR where we demonstrate loss of tumor MHC class I associates with resista…
RT @MaryamPourm: Excited to share my first author paper in @CIR_AACR where we demonstrate loss of tumor MHC class I associates with resista…
RT @MaryamPourm: Excited to share my first author paper in @CIR_AACR where we demonstrate loss of tumor MHC class I associates with resista…
RT @MaryamPourm: Excited to share my first author paper in @CIR_AACR where we demonstrate loss of tumor MHC class I associates with resista…
RT @Adri_CIR: @CIR_AACR #OnlineFirst: Single-cell technologies are used to analyze matched patient samples. Molecular & cellular changes as…
RT @Adri_CIR: @CIR_AACR #OnlineFirst: Single-cell technologies are used to analyze matched patient samples. Molecular & cellular changes as…
@CIR_AACR #OnlineFirst: Single-cell technologies are used to analyze matched patient samples. Molecular & cellular changes associated with #IL2 therapy in #melanoma are ID’d. #biomarker #immunotherapy @TBrennster @evanlipson @mikewhitemd @jmkirkwood @s
#OnlineFirst: Tumor MHC Class I Expression Associates with Intralesional Interleukin-2 Response in Melanoma. https://t.co/rrVXCmMHj4 https://t.co/XrJY5t34Xm
New article: Tumor MHC Class I Expression Associates with Intralesional Interleukin-2 Response in Melanoma https://t.co/tUn74JMOt5 #melanoma #oncology https://t.co/MYwAJyXMUh
RT @MikeAngeloLab: Cool multiomic spatial study of metastatic melanoma in human tissue. Resistance to intratumoral IL2 injection linked t…
Cool multiomic spatial study of metastatic melanoma in human tissue. Resistance to intratumoral IL2 injection linked to loss of HLA Class 1. https://t.co/8EYhow8Kmf